[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nabriva Therapeutics Plc (NBRV)

Nabriva Therapeutics Plc (NBRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 45,461
  • Shares Outstanding, K 32,015
  • Annual Sales, $ 36,940 K
  • Annual Income, $ -57,190 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.53
  • Price/Sales 1.23
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -19.20
  • Most Recent Earnings $-2.72 on 05/22/23
  • Next Earnings Date 08/02/23
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3500 +5.19%
on 07/31/23
1.9000 -25.26%
on 07/31/23
-0.0900 (-5.96%)
since 06/30/23
3-Month
1.3500 +5.19%
on 07/31/23
2.2400 -36.61%
on 05/19/23
-0.1801 (-11.26%)
since 04/28/23
52-Week
1.2150 +16.87%
on 01/09/23
8.4500 -83.20%
on 09/15/22
-3.0650 (-68.34%)
since 07/29/22

Business Summary

Nabriva Therapeutics is a biopharmaceutical company engaged in the research and development of new medicines to treat serious bacterial infections, with a focus on the pleuromutilin class of antibiotics. Nabriva Therapeutics' medicinal chemistry expertise has enabled targeted discovery of novel pleuromutilins,...

See More

Key Turning Points

3rd Resistance Point 2.3133
2nd Resistance Point 2.1067
1st Resistance Point 1.7633
Last Price 1.4200
1st Support Level 1.2133
2nd Support Level 1.0067
3rd Support Level 0.6633

See More

52-Week High 8.4500
Fibonacci 61.8% 5.6862
Fibonacci 50% 4.8325
Fibonacci 38.2% 3.9788
Last Price 1.4200
52-Week Low 1.2150

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.